Recombinant multi-species MOCS1 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine MOCS1 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
Molybdenum cofactor biosynthesis is a conserved pathway leading to the biological activation of molybdenum. The protein encoded by this gene is involved in this pathway. This gene was originally thought to produce a bicistronic mRNA with the potential to produce two proteins (MOCS1A and MOCS1B) from adjacent open reading frames. However, only the first open reading frame (MOCS1A) has been found to encode a protein from the putative bicistronic mRNA, whereas additional splice variants are likely to produce a fusion between the two open reading frames. This gene is defective in patients with molybdenum cofactor deficiency, type A. A related pseudogene has been identified on chromosome 16. [provided by RefSeq, Nov 2017]
The Alternative Names of target: MOCS1,Molybdenum cofactor biosynthesis protein 1,Cell migration-inducing gene 11 protein, Molybdenum cofactor synthesis-step 1 protein A-B,MIG11,MOCOD,MOCS1A,MOCS1B

Target products collectionGo to MOCS1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-IP0085-Ab-1/ GM-Tg-hg-IP0085-Ab-2 Human MOCS1 protein Human
GM-Tg-rg-IP0085-Ab-1/ GM-Tg-rg-IP0085-Ab-2 Rat MOCS1 protein Rat
GM-Tg-mg-IP0085-Ab-1/ GM-Tg-mg-IP0085-Ab-2 Mouse MOCS1 protein Mouse
GM-Tg-cynog-IP0085-Ab-1/ GM-Tg-cynog-IP0085-Ab-2 Cynomolgus/Rhesus macaque MOCS1 monoclonal antibody Cynomolgus/ Rhesus macaque
GM-Tg-felg-IP0085-Ab-1/ GM-Tg-felg-IP0085-Ab-2 Feline MOCS1 protein Feline
GM-Tg-cang-IP0085-Ab-1/ GM-Tg-cang-IP0085-Ab-2 Canine MOCS1 protein Canine
GM-Tg-bovg-IP0085-Ab-1/ GM-Tg-bovg-IP0085-Ab-2 Bovine MOCS1 protein Bovine
GM-Tg-equg-IP0085-Ab-1/ GM-Tg-equg-IP0085-Ab-2 Equine MOCS1 protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-IP0085-Ab-1/ GM-Tg-hg-IP0085-Ab-2; GM-Tg-rg-IP0085-Ab-1/ GM-Tg-rg-IP0085-Ab-2;
GM-Tg-mg-IP0085-Ab-1/ GM-Tg-mg-IP0085-Ab-2; GM-Tg-cynog-IP0085-Ab-1/ GM-Tg-cynog-IP0085-Ab-2;
GM-Tg-felg-IP0085-Ab-1/ GM-Tg-felg-IP0085-Ab-2; GM-Tg-cang-IP0085-Ab-1/ GM-Tg-cang-IP0085-Ab-2;
GM-Tg-bovg-IP0085-Ab-1/ GM-Tg-bovg-IP0085-Ab-2; GM-Tg-equg-IP0085-Ab-1/ GM-Tg-equg-IP0085-Ab-2
Products Name MOCS1 protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name MOCS1
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine MOCS1 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.